Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6801063 | 0.83 | FBP1 (0.37) | FBP1KDM4EALDH1A1NPC1RAB9A | |
| SCHEMBL1231111 | 0.81 | KDM4E (0.37) | KDM4EALDH1A1NPC1RAB9AGAA | |
| SCHEMBL5361361 | 0.76 | KDM4E (0.39) | KDM4EALDH1A1NPC1RAB9AGAA | |
| SCHEMBL4775600 | 0.76 | KDM4E (0.39) | KDM4EALDH1A1NPC1RAB9AGAA | |
| SCHEMBL5373030 | 0.76 | KDM4E (0.39) | KDM4EALDH1A1NPC1RAB9AGAA | |
| SCHEMBL6800350 | 0.74 | FBP1 (0.36) | FBP1KDM4EALDH1A1NPC1RAB9A | |
| SCHEMBL4219592 | 0.73 | KDM4E (0.32) | KDM4EALDH1A1GAA | |
| SCHEMBL13888687 | 0.69 | DPP4 (0.55) | FBP1KDM4EALDH1A1NPC1RAB9A | |
| SCHEMBL13888685 | 0.69 | DPP4 (0.55) | FBP1KDM4EALDH1A1NPC1RAB9A | |
| SCHEMBL4319170 | 0.68 | MEN1 (0.47) | KDM4EALDH1A1NPC1RAB9AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6825358-B2 | AS ORGANIC SEMICONDUCTORS CAN BE DISSOLVED IN COMMON ORGANIC SOLVENTS AND APPLIED TO THE SURFACE OF A SUBSTRATE USING INEXPENSIVE, LOW-TEMPERATURE SOLUTION-BASED PROCESSING SUCH AS SPIN-COATING, DIP-COATING, DROP-CASTING, ETC. | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2004-11-30 | — | — | US | disclosed |
| US-6414164-B1 | LOW COST, LOW TEMPERATURE ALTERNATIVES TO AMORPHOUS SILICON AS SEMICONDUCTING COMPONENT IN THIN FILM TRANSISTOR DEVICES | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2002-07-02 | — | — | US | disclosed |
| US-20020072618-A1 | Synthesis of soluble derivatives of sexithiophene and their use as the semiconducting channels in thin-film field-effect transistors | GLOBALFOUNDRIES U.S. INC. | 2002-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020072618-A1 | Synthesis of soluble derivatives of sexithiophene and their use as the semiconducting channels in thin-film field-effect transistors | SLC43A1, GFPT1, PHOSPHO1 | FBP1 810/4885KDM4E 152/4885ALDH1A1 3675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.